1015 related articles for article (PubMed ID: 24706089)
1. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
[TBL] [Abstract][Full Text] [Related]
2. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
Rönn F; Kesek M; Karp K; Henein M; Jensen SM
Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
6. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
Nägele H; Behrens S; Eisermann C
Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
[TBL] [Abstract][Full Text] [Related]
7. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
[TBL] [Abstract][Full Text] [Related]
8. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction.
Röger S; Rudic B; Akin I; Shchetynska-Marinova T; Fastenrath F; Tülümen E; Liebe V; El-Battrawy I; Baumann S; Kuschyk J; Borggrefe M
Clin Cardiol; 2018 Apr; 41(4):518-524. PubMed ID: 29697870
[TBL] [Abstract][Full Text] [Related]
10. First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study.
Pappone C; Augello G; Rosanio S; Vicedomini G; Santinelli V; Romano M; Agricola E; Maggi F; Buchmayr G; Moretti G; Mika Y; Ben-Haim SA; Wolzt M; Stix G; Schmidinger H
J Cardiovasc Electrophysiol; 2004 Apr; 15(4):418-27. PubMed ID: 15089990
[TBL] [Abstract][Full Text] [Related]
11. Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study.
Auricchio A; Delnoy PP; Butter C; Brachmann J; Van Erven L; Spitzer S; Moccetti T; Seifert M; Markou T; Laszo K; Regoli F;
Europace; 2014 May; 16(5):681-8. PubMed ID: 24497573
[TBL] [Abstract][Full Text] [Related]
12. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
13. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
Bianchi S; Rossi P; Schauerte P; Elvan A; Blomström-Lundqvist C; Kornet L; Gal P; Mörtsell D; Wouters G; Gemein C
Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):562-8. PubMed ID: 25878323
[TBL] [Abstract][Full Text] [Related]
14. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
[TBL] [Abstract][Full Text] [Related]
15. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
[TBL] [Abstract][Full Text] [Related]
17. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
Valls-Bertault V; Fatemi M; Gilard M; Pennec PY; Etienne Y; Blanc JJ
Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
[TBL] [Abstract][Full Text] [Related]
18. Model-based navigation of left and right ventricular leads to optimal targets for cardiac resynchronization therapy: a single-center feasibility study.
Laksman Z; Yee R; Stirrat J; Gula LJ; Skanes AC; Leong-Sit P; Manlucu J; McCarty D; Turkistani Y; Scholl D; Rajchl M; Goela A; Islam A; Thompson RT; Drangova M; White JA
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1040-7. PubMed ID: 25221334
[TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
[TBL] [Abstract][Full Text] [Related]
20. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Sharov VG; Goldstein S; Ben-Haim S; Sabbah HN
J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
